| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/28/2004 | EP0708829B1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/28/2004 | EP0690675B1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/28/2004 | CN1471587A Gene markers for lung cancer |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471537A Synthons for oligonucleotide synthesis |
| 01/28/2004 | CN1470635A Polypeptide-human protein tyrosine phosphatase 10 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470527A Polypeptide-human calcium ion regulatory secretory action protein 48 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470526A Polypeptide-human muscle BOP protein 41 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470525A Polypeptide-human SEH protein 29 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470524A Polypeptide-human transcriptional elongation factor IIS51 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470523A Polypeptide-zinc finger protein 64 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470522A Polypeptide-XRN-100 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470521A Polypeptide-mitochondrial carrier 12 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470520A Polypeptide-zine finger protein 40 and polynucleotide encoding this polypeptide |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683173 Tm leveling methods |
| 01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
| 01/27/2004 | US6683170 Including peptides which selectively bound by targeted cell so that modified fiber protein is internalized by receptor-mediated endocytosis; trimerization |
| 01/27/2004 | US6683167 Hybrid oligonucleotide phosphorothioates |
| 01/27/2004 | US6683166 Modified internucleoside linkages (ii) |
| 01/27/2004 | US6683045 Nucleosides for imaging and treatment applications |
| 01/27/2004 | US6682930 Triplex forming oligonucleotides and their use in anti-HBV |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682895 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/27/2004 | US6682888 Genes expressed in alzheimer's disease |
| 01/27/2004 | US6682887 Snp detection sequences bound to target dna are partially degraded with release of said electrophoretic tag, each released product produced from a given detection sequence has a known, unique electrophoretic mobility |
| 01/27/2004 | US6682715 Nucleosides for imaging and treatment applications |
| 01/27/2004 | CA2021489C Methods and compositions for chromosome-specific staining |
| 01/22/2004 | WO2004007773A1 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 01/22/2004 | WO2004007772A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression |
| 01/22/2004 | WO2004007771A1 Nucleic acid pre-absorption assay |
| 01/22/2004 | WO2004007751A2 Nucleic acid labeling methods |
| 01/22/2004 | WO2004007748A2 Deprotection and purification of oligonucleotides and their derivatives |
| 01/22/2004 | WO2004007710A1 Solid support having electrostatic layer and use thereof |
| 01/22/2004 | WO2004007684A2 Synthetic tag genes |
| 01/22/2004 | WO2004007664A2 Nucleic acid vectors |
| 01/22/2004 | WO2004007546A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | WO2004007543A1 Altered insulin-like growth factor binding proteins |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2004006678A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | WO2003103480A3 Gene cluster analysis for coronary artery disease |
| 01/22/2004 | WO2003102143A3 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 01/22/2004 | WO2003089906A3 Functionalized nanoparticles and methods of use |
| 01/22/2004 | WO2003048303A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | US20040014981 Cyanine dyes |
| 01/22/2004 | US20040014957 Useful as antisense agents, ribozymes, aptamers, probes/primers, or as substrate for ribonucleases when hybridized to RNA |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014955 Identification of essential genes of cryptococcus neoformans and methods of use |
| 01/22/2004 | US20040014713 Di(uridine 5')-tetraphosphate and salts thereof |
| 01/22/2004 | US20040014699 Antisense modulation of PTPRM expression |
| 01/22/2004 | US20040014644 Prevent gene expression; genetic engineering |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014113 Method for efficient RNA interference in mammalian cells |
| 01/22/2004 | US20040014105 Methods for the enrichment of low-abundance polynucleotides |
| 01/22/2004 | US20040014090 Encoded self-assembling chemical libraries (ESACHEL) |
| 01/22/2004 | US20040014076 Method for sequencing nucleic acid sequences without chain termination |
| 01/22/2004 | US20040014071 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014042 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040013573 Used to synthesize nucleic acid arrays |
| 01/22/2004 | CA2492469A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | CA2492313A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | CA2492212A1 Nucleic acid labeling methods |
| 01/22/2004 | CA2492208A1 Deprotection and purification of oligonucleotides and their derivatives |
| 01/22/2004 | CA2492203A1 Synthetic tag genes |
| 01/22/2004 | CA2491917A1 Altered insulin-like growth factor binding proteins |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382610A2 Conductive metal-containing nucleic acids |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1165584B1 2'-substituted rna preparation |
| 01/21/2004 | EP1088035B1 Efficient activated cyanine dyes |
| 01/21/2004 | CN1468861A Recombinant human immune deficiency virus fusion inhibitor and its prepn and use |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | CA2210753C Farnesyl diphosphate synthase |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/15/2004 | WO2004006161A1 Movement of multi-enzymatic nanoassemblies on recognition landscapes |
| 01/15/2004 | WO2004005889A2 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | WO2004005554A2 Antisense modulation of livin expression |
| 01/15/2004 | WO2004005553A1 Apparatus and method for isolating a nucleic acid from a sample |
| 01/15/2004 | WO2004005552A1 Antisense modulation of tfg-beta 2 expression |
| 01/15/2004 | WO2004005551A1 Antisense modulation of nf-kappa-b p50 subunit expression |
| 01/15/2004 | WO2004005534A2 Screening for alzheimer's disease |
| 01/15/2004 | WO2004005530A2 Compositions and methods for treatment and detection of multiple cancers |
| 01/15/2004 | WO2004005527A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/15/2004 | WO2004005524A1 Hepatitis c virus particle formation |
| 01/15/2004 | WO2004005507A1 Polymerase chain reaction container and process for producing the same |
| 01/15/2004 | WO2004005498A1 Chimeric gb virus b (gbv-b) |
| 01/15/2004 | WO2004005468A2 Axs gene and protein and methods related thereto |
| 01/15/2004 | WO2004005461A2 Antisense modulation of insulin-like growth factor 2 expression |
| 01/15/2004 | WO2004005460A2 Antisense modulation of hmg-coa reductase expression |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004005312A1 Antisense modulation of ptprk expression |
| 01/15/2004 | WO2004004742A1 Improved gm-csf nucleic acid sequences |